SLC25A1 has been extensively investigated in relation to cancer, and abnormal expression of SLC25A1 promotes the growth and invasion of cancer cells through metabolic regulation, making it a potentially effective treatment [49]. This evidence concerns the gene SLC25A1 and cancer.